LY2922470

CAS No. 1423018-12-5

LY2922470( LY-2922470 | LY 2922470 )

Catalog No. M11781 CAS No. 1423018-12-5

LY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM; displays no activity against PPARα/β/γ (>10 uM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 224 Get Quote
10MG 337 Get Quote
25MG 584 Get Quote
50MG 833 Get Quote
100MG 1134 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LY2922470
  • Note
    Research use only, not for human use.
  • Brief Description
    LY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM; displays no activity against PPARα/β/γ (>10 uM).
  • Description
    LY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM; displays no activity against PPARα/β/γ (>10 uM); demonstrates potent, efficacious, and durable dose-dependent reductions in glucose levels along with significant increases in insulin and GLP-1 secretion in vivo.Diabetes Phase 1 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LY-2922470 | LY 2922470
  • Pathway
    GPCR/G Protein
  • Target
    FFAR
  • Recptor
    FFAR
  • Research Area
    Metabolic Disease
  • Indication
    Diabetes

Chemical Information

  • CAS Number
    1423018-12-5
  • Formula Weight
    475.603
  • Molecular Formula
    C28H29NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 125 mg/mL 262.83 mM
  • SMILES
    O=C(C[C@@H](C1=CC=C(OCC2=CC=C(CN3CCCC4=C3C(OC)=CC=C4)S2)C=C1)C#CC)O
  • Chemical Name
    (S)-3-(4-((5-((8-methoxy-3,4-dihydroquinolin-1(2H)-yl)methyl)thiophen-2-yl)methoxy)phenyl)hex-4-ynoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hamdouchi C, et al. J Med Chem. 2016 Dec 22;59(24):10891-10916.
molnova catalog
related products
  • PBI-4050 sodium

    PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively.

  • Fasiglifam

    A potent, selective, orally bioavailable GPR40 (FFA1) agonist with EC50 of 14 nM.

  • GLPG 0974

    GLPG 0974 is a potent, selective free fatty acid receptor 2 (FFA2, GPR43) antagonist with IC50 of 95 nM.